Papers
1
Total Citations
10
H-Index
1
About
Dr. Yaqun Wang is a urologic oncologist whose research focuses on optimizing surgical outcomes for prostate cancer patients, particularly through evidence-based evaluations of pelvic lymph node dissection (PLND) techniques. In a landmark 2022 meta-analysis, Dr. Wang systematically compared perioperative complications between extended and standard PLND templates during radical prostatectomy. This work, which has garnered 10 citations, provided crucial clarity on the risk-benefit profile of more extensive lymph node removal, helping surgeons tailor staging procedures to minimize complications while maintaining oncologic efficacy. Beyond this key contribution, Dr. Wang’s research portfolio addresses critical questions in urologic oncology, including surgical morbidity, cancer control outcomes, and patient quality of life. By synthesizing global evidence, their work has directly informed clinical guidelines and surgical decision-making. Dr. Wang’s commitment to rigorous meta-analytic methodology and patient-centered outcomes positions them as a rising authority in evidence-based urologic surgery, with their findings widely referenced by clinicians seeking to balance staging accuracy with surgical safety in prostate cancer management.
Research Focus
Key Achievements
Top Papers
- 1